NCT06273761 Evaluation of Medication Management Service
| NCT ID | NCT06273761 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Medication Adherence |
| Study Type | INTERVENTIONAL |
| Enrollment | 640 participants |
| Start Date | 2024-02-06 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 640 participants in total. It began in 2024-02-06 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Medication management services (MMS) is a pharmacist-led service of optimizing the medication use and health outcomes, by promoting medication safety and enhancing the ability in self-management of health and diseases of patients and their caregivers. Yet, only limited evidence on the implementation of MMS service in Hong Kong is available. The goal of this clinical trial is to evaluate the cost effectiveness and effects of implementing MMS in community pharmacies owned by 8 non-government organizations (NGOs) in Hong Kong on humanistic and clinical outcomes in patients with hypertension and/or type II diabetes mellitus. The clinical trial aims to look into the following aspects: * To evaluate the perception and satisfaction of patients on MMS service * To investigate whether MMS could improve patients' adherence to their medication regimen, health-related quality of life, health outcomes and health service utilization, as well as their ability to understand and cope with their illness and drug-related problems * To identify and categorize the types of drug-related problems identified during MMS * To evaluate the cost-effectiveness of implementing MMS in community pharmacies MMS services will be rolled out in a total of 8 NGO community pharmacies progressively (2 pharmacies per phase) in 4 successive phases. Participants will complete the questionnaires at the following time points throughout the trial, namely 1) during recruitment, 2) baseline (1 month before MMS), 3) 3 months after MMS begins, 4) 12 months after MMS begins, and 5) 24 months after MMS begins. Researchers will compare the results of questionnaires conducted at different time points to identify the potential changes in the effects of MMS. Furthermore, researchers will link up the electronic health records of the participants and identify the potential changes in the health outcomes and health service utilizations after receiving MMS.
Eligibility Criteria
Inclusion Criteria: * aged 18 years or above * diagnosed with Type 2 diabetes mellitus and/or hypertension * having regular follow-up on Type 2 diabetes mellitus and/or hypertension at Hospital Authority * no A\&E admission/hospitalization in the past 3 months * no recent changes in medication regimen in the past 3 months * polypharmacy (taking 5 or more chronic medications) * using at least 1 high-risk medication (Anticoagulants, Oral hypoglycaemics, Insulins, psychotropic medications or immunosuppressants) * able to communicate in Cantonese and/or English Exclusion Criteria: * aged below 18 * unable to give informed consent * unable to communicate in Cantonese and/or English
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06273761 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Medication Adherence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06273761 currently recruiting?
Yes, NCT06273761 is actively recruiting participants. Contact the research team at wongick@hku.hk for enrollment information.
Where is the NCT06273761 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong, Hong Kong, Hong Kong, Hong Kong, Hong Kong, Hong Kong, Hong Kong and 4 additional locations.
Who is sponsoring the NCT06273761 clinical trial?
NCT06273761 is sponsored by The University of Hong Kong. The trial plans to enroll 640 participants.